Companies / Brazil
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Challenges Ahead For Latin America's ED Market
August 2006 | Market Trend AnalysisSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Latin America's erectile dysfunction (ED) market is recording strong sales, but competitive trends are shifting in the lucrative sector. Throughout the region, Pfizer's long-standing market leader Viagra (sildenafil) is losing ground to rivals including Lillly/ICOS's Cialis (tadalafil) and Bayer's Levitra